Patents Assigned to MSE Pharmazeutika GmbH
  • Transdermal, oral and intravenous formulations of 2, 3-dimethoxy-5-methyl-6-decaprenyl-1, 4-benzoquinone
    Publication number: 20040228910
    Abstract: Transdermal, oral and intravenous formulations of 2,3-dimethoxy-5-methyl-6-decaprenyl-1,4-benzoquinone (coenzyme Q10), containing an effective amount of pulmonary surfactant, also in combination with liposomes, in addition to usual excipients.
    Type: Application
    Filed: February 23, 2004
    Publication date: November 18, 2004
    Applicant: MSE Pharmazeutika GmbH
    Inventors: Franz Enzmann, Burkhard Lachmann
  • Ubiquinone Qn for the treatment of pain
    Publication number: 20040034107
    Abstract: Ubiquinone Qn or ubiquinone Qn precursors can be used for the treatment of pain.
    Type: Application
    Filed: April 29, 2003
    Publication date: February 19, 2004
    Applicant: MSE Pharmazeutika GmbH
    Inventor: Franz Enzmann
  • Preparation of a pulmonary surfactant for instillation and oral application
    Patent number: 6255354
    Abstract: A pulmonary surfactant formulation for instillation and oral application, containing at least 0.1% by weight of 2,3 -dimethoxy-5-methyl-6-decaprenyl-1,4-benzoquinone in addition to an effective amount of pulmonary surfactant and usual excipients.
    Type: Grant
    Filed: October 12, 1999
    Date of Patent: July 3, 2001
    Assignee: MSE Pharmazeutika GmbH
    Inventors: Franz Enzmann, Burkhard Lachmann
  • Use of 2,3-dimethoxy-5-methyl-6-decaprenyl-1,4-benzoquinone
    Patent number: 6228891
    Abstract: 2,3-Dimethoxy-5-methyl-6-decaprenyl-1,4-benzoquinone can be used for the topical and oral treatment of diseases of the skin and the mucosae of the mouth, the stomach, the bowels, the vagina and the lung.
    Type: Grant
    Filed: October 12, 1999
    Date of Patent: May 8, 2001
    Assignee: MSE Pharmazeutika GmbH
    Inventors: Franz Enzmann, Burkhard Lachmann